PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1076961
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1076961
The global Human Genetics market is estimated to be worth $65,901.3 million in 2021. Human Genetics market is expected to expand at an 20.3% CAGR during the forecast period.
Market Introduction
Human genetics is the study of how children inherit traits from their parents. Human inheritance is not fundamentally different from that of other creatures.
In genetics, the study of human heredity takes center stage. Much of this curiosity arises from a desire to understand who humans are and why they behave the way they do. On a more practical level, knowledge of human heredity is crucial for the prediction, diagnosis, and treatment of disorders with a genetic component. The study of medical genetics arose from the need to learn more about the genetic foundation of human health. In general, medicine has given human genetics a focus and purpose. Therefore the phrases medical genetics and human genetics are interchangeable.
Market Dynamics
The human genetics market is expected to increase at an exponential rate during the forecast period. The market's growth is determined by important variables such as the rise in genetic illnesses, the advancement of genomics, and the rise in gene-based therapy, among others. Because of the development of precision medicines and their use in emerging countries, the human genetic market is predicted to rise. The use of human genetics research in customized and precision medicine has spawned a new field known as pharmacogenomics. It entails optimizing drug therapy in order to reduce adverse drug reactions. Rapid advances in personalized medicine will enable it to forecast diseases in advance, allowing medical practitioners to intervene sooner and treat the condition according to the patient's unique genetic profile. Using recombinant DNA technology, Genentech Corporation recently created a monoclonal antibody called 'Trastuzumab' for the treatment of breast cancer.
Segmentation Analysis
Human Genetics Market is segmented By Methods, instruments, Applications, End Users,s and Geography. Based on application, the genetic disease segment is expected to dominate the global market with a 36% share. The market is expected to develop as the prevalence of genetic illnesses rises, genetic testing improves, and the use of genetic testing in oncology expands. According to the World Health Organization, some hereditary disorders, such as sickle cell anemia, affect roughly 72,000 babies, particularly in those with African ancestors. Sickle cell anemia, for example, is diagnosed in one out of every 500 African-American births and one out of every 1000 American births. Hemophilia, a genetic bleeding illness, affects around 6,000 people in the United Kingdom each year. Another hereditary condition that affects the digestive, respiratory, and reproductive systems is cystic fibrosis (CF). In Asia, the condition is underdiagnosed, although it affects one out of every 1000 infants in Europe.
Competitive Landscape
The global human genomics market is fairly competitive with the presence of a large number of international and national players. Industry players are relying on product approvals, product launches, mergers, and acquisitions to gain a significant share of the global Human Genetics market,. For instance, in March 2022, The United States Food and Drug Administration released two draught guidances: "Human Gene Therapy Products Incorporating Human Genome Editing" and "Chimeric Antigen Receptor T Cell Product Development." The FDA's first low-risk finding for a food animal with a deliberate genetic modification prompted the release of these draught guidance papers.
Key features of the study:
This proposed research study on Human Genetics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2022-2028), considering 2021 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Genetics market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Genetics market.
Impact of COVID-19 on Human Genetics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Genetics market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Human Genetics market, we have also included competitive landscape and key innovator analysis for the Human Genetics market
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Human Genetics market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Human Genetics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
Global Human Genetics Market Key Players
LGC Forensics
QIAGEN N.V.
Agilent Technologies
Bode Technology
Thermo Fisher Scientific Inc.
Illumina
Promega Corporation
Orchid Cellmark Inc.
GE Healthcare
Global Human Genetics Market by Instruments
Devices
Accessories
Global Human Genetics Market by Methods
Cytogenetic
Prenatal
Molecular
Presymptomatic
Global Human Genetics Market by Application
Genetic Diseases
Forensic Research
Diabetes
Cardiovascular Diseases
Cancer
Global Human Genetics Market by End User
Research centers
Hospitals
Forensic laboratories
Others
Global Human Genetics Market by Region
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa